Inhalation Drug Delivery Solutions
-
A Comprehensive Approach That's Exceptional By Design
2/2/2026
An overview of analytical capabilities to boost product quality, meet regulatory expectations, and drive development through phase‑appropriate methods and specialized testing for complex drug programs.
-
Pre-Formulation And Material Sciences
3/3/2022
Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.
-
Inhaled Product Development
3/3/2022
Our integrated capabilities and vast knowledge encompasses pre-formulation sciences, formulation development, device evaluation, clinical trial manufacturing and the clinical assessment of a variety of inhaled formats for nasal and pulmonary delivery.
-
Pharmaceutical Development
4/24/2023
Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential.
-
Pulmonary
2/27/2026
See key inhalation platforms and their advantages, showing how targeted delivery, formulation flexibility, and patient-friendly design support efficient development and stronger therapeutic outcomes.
-
Fast-Tracking Healthier Tomorrows For Patients And Our Planet
2/2/2026
A focused look at how low‑GWP propellant technologies support sustainability goals while preserving inhaler performance, offering guidance for planning regulatory readiness, device compatibility, and long‑term respiratory portfolio strategy.
-
Transforming Drug Delivery
3/1/2024
Learn how our team of scientists, engineers, and human-centered designers, as well as our world-class facilities, empower us to confidently guide your product toward a successful market launch.
-
Battelle uLAB
3/21/2024
This comprehensive suite of services encompasses the entire spectrum of user research, starting from the conceptualization of study designs to meticulous data analysis and comprehensive reporting.
-
Pulmonary Drug Delivery
2/2/2026
Modern inhalation platforms, improved formulations, and greener propellants speed development and strengthen respiratory performance, with key factors guiding device choice and clinical readiness.
-
Combination Products
4/28/2022
Kymanox provides turnkey services to bring your product from concept to commercialization — and helps keep your product on the market. Kymanox has expertise in injectables (e.g., syringes, mechanical and electromechanical autoinjectors, wearable injectors, dual chamber systems, reconstitution systems), respiratory combination products (e.g., metered dose inhalers, dry powder inhalers, nasal sprays), and in ocular products (e.g., multi-dose containers, single-use injectables).